Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine

Brain Research

Volumn 706, Issue 2, 1996, Pages 303-307

  Toggas, Stephanie M ^a   Masliah, Eliezer ^b   Mucke, Lennart ^a,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glutamate; HIV 1; N Methyl D aspartate; Neurotoxicity; Transgenic; Treatment

Indexed keywords

MEMANTINE; MICROTUBULE ASSOCIATED PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOCYTOCHEMISTRY; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSGENIC MOUSE;

EID: 0030059754     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01197-8     Document Type: Article

References (39)

1. Ali, S.F., Holson, R.R., Newport, G.D., Slikker, W. and Bowyer, J.F., Development of dopamine and N-methyl-D-aspartate systems in rat brain: the effect of prenatal phencyclidine exposure, Dev. Brain Res., 73 (1993) 25-33.
2. Benos, D.J., Hahn, B.H., Bubien, J.K., Ghosh, S.K., Mashburn, N.A., Chaikin, M.A., Shaw, G.M. and Benveniste, E.N., Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex, Proc. Natl. Acad. Sci. USA, 91 (1994) 494-498.
3. Brenner, M., Kisseberth, W.C., Su, Y., Besnard, F. and Messing, A., GFAP promoter directs astrocyte-specific expression in transgenic mice, J. Neurosci., 14 (1994) 1030-1037.
4. Budka, H. Cerebral pathology in AIDS: a new nomenclature and pathogenetic concepts, Curr. Opinion. Neurol. Neurosurg., 5 (1992) 917-923.
5. Chen, H.-S.V., Pellegrini, J.W., Aggarwal, S.K., Lei, S.Z., Warach, S., Jensen, F.E. and Lipton, S.A., Open-channel block of NMDA responses by memantine: therapeutic advantages against NMDA receptor-mediated neurotoxicity, J. Neurosci., 12 (1992) 4427-4436.
6. Dawson, V.L., Dawson, T.M., Uhl, G.R. and Snyder, S.H., Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures, Proc. Natl. Acad. Sci. USA, 90 (1993) 3256-3259.
7. Epstein, L.G. and Gendelman, H.E., Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms, Ann. Neurol., 33 (1993) 429-436.
8. Everall, I., Luthert, P. and Lantos, P., A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia, J. Neuropathol. Exp. Neurol., 52 (1993) 561-566.
9. Gelbard, H.A., Nottet, H.S.L.M., Swindells, S., Jett, M., Dzenko, K.A., Genis, P., White, R., Wang, L., Choi, Y.-B., Zhang, D., Lipton, S.A., Tourtellotte, W.W., Epstein, L.G. and Gendelman, H.E., Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin, J. Virol., 68 (1994) 4628-4635.
10. Gendelman, H.E., Lipton, S.A., Tardieu, M., Bukrinsky, M.I. and Nottet, H.S.L.M., The neuropathogenesis of HIV-1 infection, J. Leukocyte Biol., 56 (1994) 389-398.
11. Genis, P., Jett, M., Bernton, E.W., Boyle, T., Gelbard, H.A., Dzenko, K., Keane, R.W., Resnick, L., Mizrachi, Y., Volsky, D.J., Epstein, L.G. and Gendelman, H.E., Cytokines and arachidonic acid metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease, J. Exp. Med., 176 (1992) 1703-1718.
12. Giulian, D., Vaca, K. and Noonan, C.A., Secretion of neurotoxin by mononuclear phagocytes infected with HIV-1, Science, 250 (1990) 1593-1596.
13. Giulian, D., Wendt, E., Vaca, K. and Noonan, C.A., The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes, Proc. Natl. Acad. Sci. USA, 90 (1993) 2769-2773.
14. Hill, J.M., Mervis, R.F., Avidor, R., Moody, T.W. and Brenneman, D.E., HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates, Brain. Res., 603 (1993) 222-233.
15. Keilhoff, G. and Wolf, G., Memantine prevents quinolinic acid-induced hippocampal damage, Eur. J. Pharmacol., 219 (1992) 451-454.
16. Lipton, S.A., Memantine prevents HIV coat protein-induced neuronal injury in vitro, Neurology, 42 (1992) 1403-1405.
17. Lipton, S.A., Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120, NeuroReport, 3 (1992) 913-915.
18. Lipton, S.A., HIV-related neuronal injury: potential therapeutic intervention with calcium channel antagonists and NMDA antagonists, Mol. Neurobiol., 8 (1994) 181-196.
19. Lipton, S.A. and Rosenberg, P.A., Mechanisms of disease: excitatory amino acids as a final common pathway for neurologic disorders, N. Engl. J. Med., 330 (1994) 613-622.
20. Lipton, S.A., Sucher, N.J., Kaiser, P.K. and Dreyer, E.B., Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity, Neuron, 1 (1991) 111-118.
21. MacDonald, M.C., Robertson, H.A. and Wilkinson, M., Age-and dose-related NMDA induction of Fos-like immunoreactivity and c-fos mRNA in the arcuate nucleus of immature female rats, Dev. Brain. Res., 73 (1993) 193-198.
22. Masliah, E., Achim, C.L., Ge, N., DeTeresa, R., Terry, R.D. and Wiley, C.A., Spectrum of human immunodeficiency virus-associated neocortical damage, Ann. Neurol., 32 (1992) 321-329.
23. Masliah, E., Fagan, A., Terry, R., DeTeresa, R., Mallory, M. and Gage, R., Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP43 in the dentate gyrus of the adult rat, Exp. Neurol., 113 (1991) 131-142.
24. Mattson, M.P., Cheng, B., Culwell, A.R., Esch, F.S., Lieberburg, I. and Rydel, R.E., Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein, Neuron, 10 (1993) 243-254.
25. Mucke, L., Abraham, C.R., Ruppe, M.D., Rockenstein, E.M., Toggas, S.M., Alford, M. and Masliah, E., Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein, J. Exp. Med., 181 (1995) 1551-1556.
26. Mucke, L. and Eddleston, M., Astrocytes in infectious and immune-mediated diseases of the central nervous system, FASEB J., 7 (1993) 1226-1232.
27. Mucke, L., Masliah, E. and Campbell, I.L., Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines, Curr. Top. Microbiol. Immunol., 202 (1995) 187-205.
28. Müller, W.E.G., Schröder, H.C., Ushijima, H., Dapper, J. and Bormann, J., gp120 of HIV-1 induced apoptosis in rat cortical cell cultures: prevention by memantine, Eur. J. Pharmacol., 226 (1992) 209-214.
29. Pietraforte, D., Tritarelli, E., Testa, U. and Minetti, M., gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages, J. Leukocyte Biol., 55 (1994) 175-182.
30. Pittaluga, A. and Raiteri, M., HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings, Eur. J. Neurosci., 6 (1994) 1743-1749.
31. Price, R.W. and Perry, S.W., HIV, AIDS, and the Brain, Raven Press, New York, 1994.
32. Seif el Nasr, M., Peruche, B., Rossberg, C., Mennel, H.D. and Krieglstain, J., Neuroprotective effect of memantine demonstrated in vivo and in vitro, Eur. J. Pharmacol., 185 (1990) 19-24.
33. Sharer, L.R., Pathology of HIV-1 infection of the central nervous system. A review, J. Neuropathol. Exp. Neurol., 51 (1992) 3-11.
34. Sheng, M., Cummings, J., Roldan, L.A., Jan, Y.N. and Jan, L.Y., Changing subunit composition of heteromeric NMDA receptors during development of rat cortex, Nature, 368 (1994) 144-147.
35. Tardy, M., Fages, C., Riol, H., LePrince, G., Rataboul, P., Charriere-Bertrand, C. and Nunez, J., Developmental expression of the glial fibrillary acidic protein mRNA in the central nervous system and in cultured astrocytes, J. Neurochem., 52 (1989) 162-167.
36. Thomas, F.P., Chalk, C., Lalonde, R., Robitaille, Y. and Jolicoeur, P., Expression of human immunodeficiency virus type 1 in the nervous sytem of transgenic mice leads to neurological disease, J. Virol., 68 (1994) 7099-7107.
37. Toggas, S.M., Masliah, E., Rockenstein, E.M., Rall, G.F., Abraham, C.R. and Mucke, L., Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice, Nature, 367 (1994) 188-193.
38. Wiley, C.A., Masliah, E., Morey, M., Lemere, C., DeTeresa, R., Grafe, M., Hansen, L. and Terry, R., Neocortical damage during HIV infection, Ann. Neurol., 29 (1991) 651-657.
39. Williams, K., Russell, S.L., Shen, Y.M. and Molinoff, P.B., Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro, Neuron, 10 (1994) 267-278.